| Name |
Format |
Description |
Link |
| NACI Summary Influenza 2019–2020 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a01-eng.pdf |
| NACI Summary Influenza 2019–2020 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a01f-fra.pdf |
| When to use vaccine effectiveness studies |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a02-eng.pdf |
| When to use vaccine effectiveness studies |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a02f-fra.pdf |
| CPIP: Public health strategy 2019 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a03-eng.pdf |
| CPIP: Public health strategy 2019 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a03f-fra.pdf |
| Increase in Serogroup W Neisseria meningitidis 2019 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a04-eng.pdf |
| Increase in Serogroup W Neisseria meningitidis 2019 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a04f-fra.pdf |
| 2018–2019 influenza vaccine low effectiveness against A(H3N2) |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a05-eng.pdf |
| 2018–2019 influenza vaccine low effectiveness against A(H3N2) |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a05f-fra.pdf |
| CCDR: Volume 45-6 June 6, 2019: Influenza: An update |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06-eng.pdf |
| CCDR: Volume 45-6 June 6, 2019: Influenza: An update |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06f-fra.pdf |
| NACI Summary Influenza 2019–2020 |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/article-1-naci-influenza-vaccine-statement-2019-2020.html |
| When to use vaccine effectiveness studies |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/article-2-influenza-vaccine-effectiveness-studies-vaccination-decision.html |
| CPIP: Public health strategy 2019 |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/article-3-canadian-pandemic-influenza-preparedness-public-health-strategy.html |
| Increase in Serogroup W Neisseria meningitidis 2019 |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/article-4-increase-serogroup-w-neisseria-meningitidis-invasive-meningococal.html |
| 2018–2019 influenza vaccine low effectiveness against A(H3N2) |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/article-5-id-news.html |
| CCDR: Volume 45-6 June 6, 2019: Influenza: An update |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019.html |
| NACI Summary Influenza 2019–2020 |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-6-6-juin-2019/article-1-declaration-ccni-vaccination-antigrippale-2019-2020.html |
| When to use vaccine effectiveness studies |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-6-6-juin-2019/article-2-etudes-efficacite-reelle-vaccin-antigrippal-decider-vacciner.html |
| CPIP: Public health strategy 2019 |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-6-6-juin-2019/article-3-preparation-grippe-pandemique-strategie-mesures-sante-publique.html |
| Increase in Serogroup W Neisseria meningitidis 2019 |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-6-6-juin-2019/article-4-hausse-meningococcie-invasive-serogroupe-w-neisseria-meningitidis.html |
| 2018–2019 influenza vaccine low effectiveness against A(H3N2) |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-6-6-juin-2019/article-5-actualites-sur-les-mi.html |
| CCDR: Volume 45-6 June 6, 2019: Influenza: An update |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-6-6-juin-2019.html |